Separation of peptides of "middle" molecular weight from biological fluids of patients with uremia
Fürst, P.; Bergström, J.; Gordon, A.; Johnsson, E.; Zimmerman, L.
Kidney International. Supplement 1975(3): 272-275
1975
ISSN/ISBN: 0098-6577 PMID: 1057698 Document Number: 88890
Document emailed within 1 workday
Related Documents
Brunner, H.; Essers, U.; Lamberts, B.; Heintz, R. 1976: Separation of bone-marrow-toxic factors from high molecular urine fractions of healthy persons and patients with uremia through dialysis in a desaggregated system Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1459-1462Tewari, S.N.; Shukla, S.K. 1977: Separation and identification of 1.4-benzodiazepine drugs present in the biological fluids by two dimensional T.l.c Die Pharmazie 32(8-9): 536
Sperschneider, H.; Spustova, V.; Stein, G.; Dzurik, R. 1982: Middle molecular weight substances in the cerebrospinal fluid of uremic patients Clinical Nephrology 17(6): 298-302
Rhodes, G.R.; Boppana, V.K. 1988: High-performance liquid chromatographic analysis of arginine-containing peptides in biological fluids by means of a selective post-column reaction with fluorescence detection Journal of Chromatography 444: 123-131
Sadowski, Rław.; Gadzała-Kopciuch, R.; Buszewski, Bław. 2019: Recent Developments in the Separation of Low Molecular Weight Heparin Anticoagulants Current Medicinal Chemistry 26(1): 166-176
Wustrow, T.P. 1991: Interactions and biological mechanisms of action of molecular signal peptides. II. Interleukin 2 (IL-2) Hno 39(9): 323-331
Chiancone, E.; Gattoni, M.; Giampietro, P.G.; Ragno, V.; Businco, L. 1995: Detection of undegraded beta-lactoglobulins and evaluation of the molecular weight of peptides in hydrolysate cow's milk formulae Journal of Investigational Allergology and Clinical Immunology 5(4): 228-231
Fiessinger, J.N.; Chatellier, G. 1996: Evaluation of an intervention on the prescription and biological surveillance of low-molecular weight heparins in medicine Presse Medicale 25(36): 1777-1780
Titov, V.N. 2007: Microalbuminuria is a test for low molecular-weight biological impurities in the body's intercellular environment Klinicheskaia Laboratornaia Diagnostika 12: 3-15
Le Querrec, A.; Derlon, A.; Deshayes, J.P.; Lefrançois, C.; Sillard, B.; Delassus, P.; Viel, J.F.; Kher, A.; Thomas, M. 1987: Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165) Journal des Maladies Vasculaires 12 Suppl B: 99-101
Murty, B.S.; Prakash, V.; Rao, M.S. 1990: Determination of molecular weight and related hydrodynamic parameters of high molecular weight protein fraction from a few oilseeds Indian Journal of Biochemistry and Biophysics 27(5): 295-299
Lamberts, B.; Brunner, H.; Ochs, H.G.; Heintz, R. 1976: Effect of high-molecular urine fractions of healthy persons and patients with uremia on the rate of gluconeogenesis in kidney cortex slices of the rat Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1453-1456
Saito, A.; Suzuki, I.; Chung, T.G.; Okamoto, T.; Hotta, T. 1986: Separation of an inhibitor of erythropoiesis in "middle molecules" from hemodialysate from patients with chronic renal failure Clinical Chemistry 32(10): 1938-1941
Trusov, V.V.; Bazhenov, A.N. 1989: Importance of determining the beta2-microglobulin level in biological fluids in patients with rheumatoid arthritis Terapevticheskii Arkhiv 61(5): 46-48
Dobrotina, N.A.; Raimond, T.I.; Nosyreva, N.N.; Andrianova, V.N. 1970: Functional state of the vascular system and electrolyte gradients in biological fluids in patients with dermatoses Vestnik Dermatologii i Venerologii 44(11): 32-36
Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399
Kugaevskaia, E.V.; Pavlikhina, L.V.; Eliseeva, I.E. 1994: Participation of serine proteinases in transforming the high molecular weight (600 kDa) form of angiotensin 1-converting enzyme into the low molecular weight form (190 kDa) Voprosy Meditsinskoi Khimii 40(3): 9-11
Volkova, Z.I.; Astakhova, T.A.; Trofimova, T.M.; Mul'diiarov, P.I. 1988: Glycosaminoglycans and beta-glucuronidase in peripheral blood cells and biological fluids of patients with rheumatoid arthritis Voprosy Meditsinskoi Khimii 34(3): 53-59
Iaremchuk, A.D.; El'skaia, A.V. 1983: Biological activity of tRNA, aminoacyl-tRNA-synthetases and composition of their high molecular weight complexes in regenerating rat liver Ukrainskii Biokhimicheskii Zhurnal 55(4): 363-367
Brieger, D.; Dawes, J. 1996: Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments--comparison with unfractionated heparin Thrombosis and Haemostasis 75(5): 740-746